G6PD deficiency in male individuals infected by Plasmodium vivax malaria in the Brazilian Amazon: A cost study

Malaria Journal

Volumn 14, Issue 1, 2015, Pages

  Peixoto, Henry M ^a,b   Brito, Marcelo Am ^c,d   Romero, Gustavo As ^a,e   Monteiro, Wuelton M ^c,d   De Lacerda, Marcus Vg ^c,d,f   De Oliveira, Maria Regina F ^a,e  

^a UNIVERSITY OF BRASILIA   (Brazil)

^b University Hospital of Brasilia   (Brazil)

^c Tropical Medicine Foundation Dr Heitor Vieira Dourado   (Brazil)

^d UNIVERSIDADE DO ESTADO DO AMAZONAS   (Brazil)

^e National Institute for Science and Technology for Health Technology Assessment (IATS/CNPq)   (Brazil)

^f INSTITUTO LEÔNIDAS E MARIA DEANE   (Brazil)

Author keywords

Economic analysis; Glucose 6 phosphate dehydrogenase deficiency; Haemolysis; Malaria; Plasmodium vivax; Primaquine

Indexed keywords

CHLOROQUINE; PRIMAQUINE; ANTIMALARIAL AGENT;

ARTICLE; BRAZIL; DIAGNOSTIC TEST; DRUG COST; ECONOMIC EVALUATION; EPIDEMIOLOGICAL DATA; GLUCOSE 6 PHOSPHATE DEHYDROGENASE DEFICIENCY; HEALTH CARE COST; HEALTH CARE SYSTEM; HOSPITALIZATION; HUMAN; MALE; PLASMODIUM VIVAX; PLASMODIUM VIVAX MALARIA; PUBLIC HEALTH SERVICE; SENSITIVITY ANALYSIS; ECONOMICS; GLUCOSEPHOSPHATE DEHYDROGENASE DEFICIENCY; MALARIA, VIVAX; PARASITOLOGY; PHYSIOLOGY;

ANTIMALARIALS; BRAZIL; GLUCOSEPHOSPHATE DEHYDROGENASE DEFICIENCY; HUMANS; MALARIA, VIVAX; MALE; PLASMODIUM VIVAX; PRIMAQUINE;

EID: 84961287873     PISSN: None     EISSN: 14752875     Source Type: Journal    
DOI: 10.1186/s12936-015-0647-x     Document Type: Article

References (50)

1. Cappellini MD, Fiorelli G. Glucose-6-phosphate dehydrogenase deficiency. Lancet. 2008;371:64-74.
2. Beutler E. Glucose-6-phosphate dehydrogenase deficiency: a historical perspective. Blood. 2008;111:16-24.
3. Minucci A, Moradkhani K, Jing M, Zuppi C, Giardina B, Capoluongo E. Blood cells, molecules, and diseases glucose-6-phosphate dehydrogenase (G6PD) mutations database: Review of the " old " and update of the new mutations. Blood Cells Mol Dis. 2012;48:154-65.
4. Von Seidlein L, Auburn S, Espino F, Shanks D, Cheng Q, McCarthy J, et al. Review of key knowledge gaps in glucose-6-phosphate dehydrogenase deficiency detection with regard to the safe clinical deployment of 8-aminoquinoline treatment regimens: a workshop report. Malar J. 2013;12:112.
5. Monteiro WM, Franca GP, Melo GC, Queiroz ALM, Brito M, Peixoto HM, et al. Clinical complications of G6PD deficiency in Latin American and Caribbean populations: systematic review and implications for malaria elimination programmes. Malar J. 2014;13:70.
6. Domingo GJ, Satyagraha AW, Anvikar A, Baird K, Bancone G, Bansil P, et al. G6PD testing in support of treatment and elimination of malaria: recommendations for evaluation of G6PD tests. Malar J. 2013;12:391.
7. Howes RE, Piel FB, Patil AP, Nyangiri O, Gething PW, Dewi M, et al. G6PD deficiency prevalence and estimates of affected populations in malaria endemic countries: a geostatistical model-based map. PLoS Med. 2012;9:e1001339.
8. Ministério da Saúde. Sistema de informação de Vigilância Epidemiológica (SIVEP-Malária) [ http://portalweb04.saude.gov.br/sivep-malaria/default.asp ]
9. Santana MS, Monteiro WM, Siqueira AM, Costa MF, Sampaio V, Lacerda MV, et al. Glucose-6-phosphate dehydrogenase deficient variants are associated with reduced susceptibility to malaria in the Brazilian Amazon. Trans R Soc Trop Med Hyg. 2013;107:301-6.
10. Fundação de Medicina Tropical Dr. Heitor Vieira Dourado (FMT-HVD). Banco de dados - deficiência da glicose-6-fosfato-desidrogenase (2009-2011). Manaus: FMT-HVD; 2011.
11. Gething PW, Elyazar IRF, Moyes CL, Smith DL, Battle KE, Guerra CA, et al. A long neglected world malaria map: Plasmodium vivax endemicity in 2010. PLoS Negl Trop Dis. 2012;6:e1814.
12. Ministério da Saúde. Guia prático de tratamento da malária no Brasil. Brasília: Ministério da Saúde; 2010.
13. Wells TNC, Burrows JN, Baird JK. Targeting the hypnozoite reservoir of Plasmodium vivax: the hidden obstacle to malaria elimination. Trends Parasitol. 2010;26:145-51.
14. Alonso PL, Brown G, Arevalo-Herrera M, Binka F, Chitnis C, Collins F, et al. A research agenda for malaria eradication: drugs. PLoS Med. 2011;8:e1000402.
15. Lacerda MVG, Fragoso SCP, Alecrim MGC, Alexandre M, Magalhães BML, Siqueira AM, et al. Postmortem characterization of patients with clinical diagnosis of Plasmodium vivax malaria: to what extent does this parasite kill? Clin Infect Dis. 2012;55:e67-74.
16. Superintendência do Desenvolvimento da Amazônia. Amazônia Legal [ http://www.sudam.gov.br/demografia/50-amazonialegal ]
17. Ramos Júnior WM, Sardinha JF, Costa MR, Santana MS, Alecrim MG, Lacerda MV. Clinical aspects of hemolysis in patients with P. vivax malaria treated with primaquine, in the Brazilian Amazon. Brazilian J Infect Dis. 2010;14:410-2.
18. Fundação de Medicina Tropical Dr. Heitor Vieira Dourado. Rotinas da Malária. Manaus: Fundação de Medicina Tropical Dr. Heitor Vieira Dourado; 2014.
19. Recht J, Ashley E, White N. Safety of 8-Aminoquinoline Antimalarial Medicines. Geneva: World Health Organization; 2014.
20. Ministério da Saúde. Sistema de Gerenciamento da Tabela de Procedimentos, Medicamentos e OPM do SUS [ http://www.sudam.gov.br/demografia/50-amazonialegal ]
21. Ministério da Saúde. Banco de Preços em Saúde [ http://aplicacao.saude.gov.br/bps/login.jsf ]
22. Instituto Brasileiro de Geografia e Estatística. Sistema Nacional de Índices de Preços ao Consumidor [ http://www.ibge.gov.br/home/estatistica/indicadores/precos/inpc-ipca/defaultseriesHist.shtm ]
23. Ministério da Saúde. Manual de diagnóstico laboratorial da malária. Brasília: Ministério da Saúde; 2005.
24. Macauley C. Aggressive active case detection: a malaria control strategy based on the Brazilian model. Soc Sci Med. 2005;60:563-73.
25. Oliveira MRF. Cost-effectiveness analysis of rapid test for the diagnosis of new malaria cases in twelve endemic municipalities of the State of Pará. PhD thesis. Universidade de São Paulo, Faculdade de Saúde Pública; 2009.
26. Fernando SD, Karunaweera ND, Fernando WP, Attanayake N, Wickremasinghe R. A cost analysis of the use of the rapid, whole-blood, immunochromatographic P.f/P.v assay for the diagnosis of Plasmodium vivax malaria in a rural area of Sri Lanka. Ann Trop Med Parasitol. 2004;98:5-13.
27. Walker D, Kumaranayake L. Allowing for differential timing in cost analyses: discounting and annualization. Health Policy Plan. 2002;17:112-8.
28. Weinstein MC, Siegel JE, Gold MR, Kamlet MS, Russell LB. Recommendations of the panel on cost-effectiveness in health and medicine. JAMA. 1996;276:1253-8.
29. Phillips M, Mills A, Dye C. Directrices para el analisis del costo-eficacia de la lucha atnivectorial. Geneva: WHO; 1996.
30. Oliveira MRF, de Castro GA, Toscano CM. Cost effectiveness of OptiMal® rapid diagnostic test for malaria in remote areas of the Amazon Region, Brazil. Malar J. 2010;9:277.
31. World Health Organization - Regional Office for the Western Pacific. Malaria light microscopy - creating a culture of quality. Kuala Lumpur: World Health Organization; 2005.
32. Ministério da Saúde. Sistema de Informação de Insumos Estratégicos [ http://portalweb04.saude.gov.br/sies/ ]
33. Fundação de Medicina Tropical Dr. Heitor Vieira Dourado (FMT-HVD). Custos com a nutrição hospitalar. Manaus: FMT-HVD; 2011.
34. Secretaria de Estado da Saúde do Amazonas (SES/AM). Tabela de vencimentos e gratificação de saúde. Manaus: SES/AM; 2011.
35. Oliveira-Ferreira J, Lacerda MVG, Brasil P, Ladislau JLB, Tauil PL, Daniel-Ribeiro CT. Malaria in Brazil: an overview. Malar J. 2010;9:115.
36. Ferreira ACS, Suárez-Mutis MC, Campos MR, de Castro CGSO. Primary health care in municipalities at high risk for malaria. Rev Lat Am Enfermagem. 2011;19:1281-8.
37. Etim S, Ogbeche J. Household responses to malaria: illness perception, cost implications and treatment-seeking behavior of mothers in Calabar, Nigeria. Malar J. 2014;13 Suppl 1:102.
38. Carter R, Mendis KN. Evolutionary and historical aspects of the burden of malaria. Clin Microbiol Rev. 2002;15:564-94.
39. Battle KE, Karhunen MS, Bhatt S, Gething PW, Howes RE, Golding N, et al. Geographical variation in Plasmodium vivax relapse. Malar J. 2014;13:144.
40. Vitor-Silva S, Reyes-Lecca RC, Pinheiro TRA, Lacerda MVG. Malaria is associated with poor school performance in an endemic area of the Brazilian Amazon. Malar J. 2009;8:230.
41. Beutler E, Duparc S. Glucose-6-phosphate dehydrogenase deficiency and antimalarial drug development. Am J Trop Med Hyg. 2007;77:779-89.
42. Kondrashin A, Baranova AM, Ashley EA, Recht J, White NJ, Sergiev VP. Mass primaquine treatment to eliminate vivax malaria: lessons from the past. Malar J. 2014;13:51.
43. Llanos-Cuentas A, Lacerda MV, Rueangweerayut R, Krudsood S, Gupta SK, Kochar SK, et al. Tafenoquine plus chloroquine for the treatment and relapse prevention of Plasmodium vivax malaria (DETECTIVE): a multicentre, double-blind, randomised, phase 2b dose-selection study. Lancet. 2014;383:1049-58.
44. Khneisser I, Adib SM, Loiselet J, Megarbane A. Cost-benefit analysis of G6PD screening in Lebanese newborn males. J Med Liban. 2007;55:129-32.
45. Ministério do Planejamento, Orçamento e Gestão. Orçamento Federal [ http://www.orcamentofederal.gov.br/orcamentos-anuais/orcamento-2010/orcamentos-anuais-view?anoOrc∈=∈2010 ]
46. Monteiro WM, Val FF, Siqueira AM, Franca GP, Sampaio VS, Melo GC, et al. G6PD deficiency in Latin America: systematic review on prevalence and variants. Mem Inst Oswaldo Cruz. 2014;109:553-68.
47. Oliveira MRF, Giozza SP, Peixoto HM, Romero GAS. Cost-effectiveness of diagnostic for malaria in extra-Amazon Region, Brazil. Malar J. 2012;11:390.
48. TM G6PD deficiency screening test, a point-of-care diagnostic for primaquine therapy screening. PLoS ONE. 2011;6:e28357.
49. Osorio L, Carter N, Arthur P, Bancone G, Gopalan S, Gupta SK, et al. Performance of BinaxNOW G6PD deficiency point-of-care diagnostic in P. vivax-infected subjects. Am J Trop Med Hyg. 2015;92:22-7.
50. White MT, Conteh L, Cibulskis R, Ghani AC. Costs and cost-effectiveness of malaria control interventions - a systematic review. Malar J. 2011;10:337.